Abstract
Twentyeight (28) patients with Idiopathic sudden hearing loss (SHL) were treated with Diatrizoate compounds (1 ml urografin 76%) containing—sodium Diatrizoate 0.1g & Meglumine Diatrizoate 0.66g after complete clinical and audiological evaluation. All the patients of SHL of not more than 45 days of onset were selected. Of these patients 19 cases (67.7%) had beneficial response with Diatrizoate Compounds (Urografin) Treatment. These patients were followed up to 4 years.
Similar content being viewed by others
References
Emmett J. R. & Shea J.J. (1979), Diatrizoate Meglumine (Hypaque) Treatment for SHL,Laryngoscope,89: 1229–1238.
Morimitsu T. (1977), New Theory and Treatment for sudden deafness. In proceeding of the Shambaugh V International Workshop on Middle-Ear Miccrosurgery and Fluctuant Hearing Loss: G. E. Shambaugh and J. J. Shea (eds)Strode publishers, Inc, Huntsrille, Ala, pp 412–421.
Shea J. J. and Emmett J. R. (1977), Evaluation of Diatrizoate Meglumine (Hypaque) in treatment of SHLLaryngoscope,87: 1809–1814.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Talsania, J.R., Ranade, P.N. Diatrizoate compounds (urografin) treatment for sudden hearing loss. Indian J Otolaryngol 41, 100–103 (1989). https://doi.org/10.1007/BF02994223
Issue Date:
DOI: https://doi.org/10.1007/BF02994223